The novel treatment of this peptide represents a significant advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide167242.link4blogs.com/62862881/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment